NEW YORK (GenomeWeb News) – Dutch firm InteRNA Technologies today said that it has joined the SIROCCO research consortium, a group of 25 labs and companies from 10 countries studying the use of RNA silencing for therapeutic applications, such as treating cancer.
 
SIROCCO stands for “Silencing RNAs: organizers and coordinators of complexity in eukaryotic organisms.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.